Rebecca Taub
Director at Madrigal Pharmaceuticals, Inc. (MDGL)
Purchase track record
Not enough history. Based on 0 purchases with a full 90 days of price history.
—
Avg. 90-day return—
vs. S&P 500—
Beat the market—
Paper profit on buys$0
Total bought / sold$0 / $21.7M
Reported trades
| Filed | Stock | Type | Shares | Price | Value | Since |
|---|---|---|---|---|---|---|
| Mar 6SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 491452,213 held (−0%) | $431.94 | $212K | +9.2% |
| Jan 26SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 647452,704 held (−0%) | $492.42 | $319K | -4.2% |
| Jan 20SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell | 2,238453,351 held (−0%) | $490.77 | $1.1M | -3.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 40455,789 held (−0%) | $545.79 | $22K | -13.6% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 200455,589 held (−0%) | $551.24 | $110K | -14.4% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 960473,039 held (−0%) | $512.02 | $492K | -7.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 960472,079 held (−0%) | $513.12 | $493K | -8.1% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 937471,142 held (−0%) | $514.63 | $482K | -8.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,578469,564 held (−0%) | $515.82 | $814K | -8.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 521469,043 held (−0%) | $516.81 | $269K | -8.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 2,044466,999 held (−0%) | $517.84 | $1.1M | -8.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 970466,029 held (−0%) | $518.67 | $503K | -9.0% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 539465,490 held (−0%) | $519.89 | $280K | -9.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 440465,050 held (−0%) | $521.11 | $229K | -9.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 588464,462 held (−0%) | $521.95 | $307K | -9.6% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 732463,730 held (−0%) | $522.98 | $383K | -9.8% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,335462,395 held (−0%) | $524.06 | $700K | -10.0% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,489460,906 held (−0%) | $525.12 | $782K | -10.2% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 913459,993 held (−0%) | $526.05 | $480K | -10.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,135458,858 held (−0%) | $526.95 | $598K | -10.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 465458,393 held (−0%) | $528.16 | $246K | -10.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 554457,839 held (−0%) | $529.28 | $293K | -10.9% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 256457,583 held (−0%) | $530.45 | $136K | -11.1% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 30457,553 held (−0%) | $531.05 | $16K | -11.2% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 40457,513 held (−0%) | $532.50 | $21K | -11.4% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 271457,242 held (−0%) | $534.18 | $145K | -11.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 89457,153 held (−0%) | $534.93 | $48K | -11.8% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 299456,854 held (−0%) | $535.80 | $160K | -12.0% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 385456,469 held (−0%) | $536.88 | $207K | -12.1% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 40456,429 held (−0%) | $537.84 | $22K | -12.3% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 400456,029 held (−0%) | $539.26 | $216K | -12.5% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 40455,989 held (−0%) | $540.26 | $22K | -12.7% |
| Jan 13SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 400455,589 held (−0%) | $542.72 | $217K | -13.1% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 491479,203 held (−0%) | $547.76 | $269K | -13.9% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 369478,834 held (−0%) | $548.56 | $202K | -14.0% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 486478,348 held (−0%) | $550.07 | $267K | -14.2% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 4,723473,625 held (−1%) | $550.99 | $2.6M | -14.4% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 4,410469,215 held (−1%) | $551.85 | $2.4M | -14.5% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 3,857465,358 held (−1%) | $552.81 | $2.1M | -14.7% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 3,087462,271 held (−1%) | $553.88 | $1.7M | -14.8% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 1,027461,244 held (−0%) | $554.84 | $570K | -15.0% |
| Dec 12SEC | MDGLMadrigal Pharmaceuticals, Inc. | Sell Plan | 200461,044 held (−0%) | $555.39 | $111K | -15.1% |
- Sell
Director Rebecca Taub sold $22K of MDGL at $545.79 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Rebecca Taub sold $110K of MDGL at $551.24 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Rebecca Taub sold $492K of MDGL at $512.02 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Rebecca Taub sold $493K of MDGL at $513.12 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Rebecca Taub sold $482K of MDGL at $514.63 — pre-scheduled 10b5-1 plan sale.
- Sell
Director Rebecca Taub sold $814K of MDGL at $515.82 — pre-scheduled 10b5-1 plan sale.